Compound Detail
CHEMBL4303669
ZOLEDRONIC ACID 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
38
Targets
104
Activities
3
Assay Types
5
PK Parameters
20
Publications
25
Known Names
20
Indications
1
Mechanisms
Molecular Properties
272.1
MW (Da)
-1.12
ALogP
5
HBA
5
HBD
153.1
PSA (Ų)
0.43
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Farnesyl diphosphate synthase inhibitor | INHIBITOR | Farnesyl pyrophosphate synthase | ✓ | ✓ |
Indications
Bone Diseases Fractures, Bone Hypercalcemia Multiple Myeloma Neoplasm Metastasis Neoplasm Metastasis Osteitis Deformans Osteitis Deformans Osteoporosis Osteoporosis, Postmenopausal Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Arthritis, Rheumatoid Bone Diseases, Metabolic Bone Neoplasms Breast Neoplasms Breast Neoplasms Carcinoma, Hepatocellular
ATC Classification
M05BA08
zoledronic acid
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: DRUGS FOR TREATMENT OF BONE DISEASES
Activity Summary
IC50 85 meas. best 9.62
EC50 13 meas. best 6.31
Ki 6 meas. best 10.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Farnesyl pyrophosphate synthase CHEMBL1782 | Ki | 10.15 | 8.61 | 0.1 | 2 |
| Farnesyl pyrophosphate synthase CHEMBL1782 | IC50 | 9.62 | 7.5617 | 0.2 | 23 |
| Mus musculus CHEMBL375 | IC50 | 8.7 | 6.8967 | 2.0 | 3 |
| Farnesyl pyrophosphate synthase CHEMBL2150832 | Ki | 8.0 | 8.0 | 10.0 | 1 |
| Farnesyl pyrophosphate synthase CHEMBL3693 | Ki | 7.96 | 7.96 | 11.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.42 | 6.7867 | 38.0 | 6 |
| Carbonic anhydrase 2 CHEMBL205 | IC50 | 7.21 | 7.21 | 62.0 | 2 |
| Carbonic anhydrase 14 CHEMBL3510 | IC50 | 7.04 | 7.04 | 92.0 | 2 |
| Farnesyl pyrophosphate synthase CHEMBL3693 | IC50 | 6.96 | 6.96 | 110.0 | 1 |
| Geranylgeranyl pyrophosphate synthase BTS1 CHEMBL1075251 | Ki | 6.58 | 6.58 | 260.0 | 1 |
| Carbonic anhydrase 12 CHEMBL3242 | IC50 | 6.5 | 6.5 | 316.0 | 2 |
| Butyrophilin subfamily 3 member A1 CHEMBL4105758 | EC50 | 6.31 | 5.14 | 486.6 | 4 |
| Geranylgeranyl pyrophosphate synthase BTS1 CHEMBL1075251 | IC50 | 6.18 | 6.18 | 660.0 | 1 |
| HFF CHEMBL614071 | IC50 | 6.1 | 5.35 | 790.0 | 4 |
| Toxoplasma gondii CHEMBL612888 | EC50 | 6.08 | 6.08 | 840.0 | 1 |
| Farnesyl diphosphate synthase CHEMBL1075078 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Geranylgeranyl pyrophosphate synthase CHEMBL4769 | Ki | 5.57 | 5.57 | 2700.0 | 1 |
| Dictyostelium discoideum CHEMBL612373 | IC50 | 5.54 | 5.54 | 2900.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.27 | 5.27 | 5400.0 | 1 |
| Carbonic anhydrase 9 CHEMBL3594 | IC50 | 5.27 | 5.27 | 5323.0 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.19 | 5.0667 | 6400.0 | 3 |
| Toxoplasma gondii CHEMBL612888 | IC50 | 5.17 | 5.17 | 6700.0 | 1 |
| 72 kDa type IV collagenase CHEMBL333 | IC50 | 5.16 | 5.16 | 7000.0 | 2 |
| J774 CHEMBL614123 | IC50 | 5.11 | 5.11 | 7800.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 5.07 | 5.07 | 8600.0 | 1 |
| CFPAC-1 CHEMBL613506 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| PANC-1 CHEMBL614139 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| BXPC-3 CHEMBL614530 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| HeLa CHEMBL399 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| SiHa CHEMBL612542 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Ca-Ski CHEMBL1075403 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| RPMI-8226 CHEMBL614882 | EC50 | 4.96 | 4.96 | 11000.0 | 2 |
| NCI-H460 CHEMBL396 | IC50 | 4.93 | 4.93 | 11700.0 | 1 |
| Entamoeba histolytica CHEMBL612853 | IC50 | 4.92 | 4.92 | 12000.0 | 2 |
| Matrix metalloproteinase-14 CHEMBL3869 | IC50 | 4.9 | 4.9 | 12600.0 | 1 |
| MIA PaCa-2 CHEMBL614725 | EC50 | 4.87 | 4.87 | 13400.0 | 1 |
| SF-268 CHEMBL613977 | IC50 | 4.84 | 4.84 | 14300.0 | 1 |
| PANC-1 CHEMBL614139 | EC50 | 4.79 | 4.79 | 16100.0 | 1 |
| Neutrophil collagenase CHEMBL4588 | IC50 | 4.75 | 4.75 | 17600.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.64 | 4.6 | 23000.0 | 2 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.46 | 4.46 | 35000.0 | 1 |
| LoVo CHEMBL614721 | IC50 | 4.46 | 4.46 | 34914.0 | 1 |
| Matrix metalloproteinase-9 CHEMBL321 | IC50 | 4.28 | 4.28 | 52000.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.22 | 4.125 | 60000.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 4.21 | 4.21 | 61582.0 | 1 |
| Geranylgeranyl pyrophosphate synthase CHEMBL4769 | IC50 | 4.01 | 4.0025 | 97000.0 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.2 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.78 | - | Homo sapiens |
| MRT | 4.5 | hr | Homo sapiens |
| T1/2 | 11.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine